Your browser doesn't support javascript.
loading
PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinoma.
Paz, Mariana M; Ferretti, Giulia D S; Martins-Dinis, Mafalda M C; Ferreira, Beatriz I S; Faier-Pereira, Amanda; Barnoud, Thibaut; Moreira, Otacilio C; Silva, Jerson L; Cordeiro, Yraima; Rangel, Luciana P.
Afiliação
  • Paz MM; Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Ferretti GDS; Institute of Medical Biochemistry Leopoldo de Meis, National Institute of Science and Technology for Structural Biology and Bioimaging, National Center of Nuclear Magnetic Resonance Jiri Jonas, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Martins-Dinis MMC; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, United States.
  • Ferreira BIS; Institute of Medical Biochemistry Leopoldo de Meis, National Institute of Science and Technology for Structural Biology and Bioimaging, National Center of Nuclear Magnetic Resonance Jiri Jonas, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Faier-Pereira A; Real Time PCR Platform RPT09A, Laboratory of Molecular Virology and Parasitology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Barnoud T; Real Time PCR Platform RPT09A, Laboratory of Molecular Virology and Parasitology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Moreira OC; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, United States.
  • Silva JL; Real Time PCR Platform RPT09A, Laboratory of Molecular Virology and Parasitology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Cordeiro Y; Institute of Medical Biochemistry Leopoldo de Meis, National Institute of Science and Technology for Structural Biology and Bioimaging, National Center of Nuclear Magnetic Resonance Jiri Jonas, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Rangel LP; Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Front Mol Biosci ; 10: 1165132, 2023.
Article em En | MEDLINE | ID: mdl-37101558

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Mol Biosci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Mol Biosci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça